Revenue grew 5.9% to over £710 million, with stable 20% EBITDA margin and strong cash conversion. Expansion in Australia is delivering accretive returns, and a £50 million share buyback reflects confidence in future growth. Leverage remains conservative at 1.63x.Based on CVS Group plc [CVSG] Q4 202…
Revenue grew 5.9% to over £710 million, with stable 20% EBITDA margin and strong cash conversion. Expansion in Australia is delivering accretive returns, and a £50 million share buyback reflects confidence in future growth. Leverage remains conservative at 1.63x.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.